Literature DB >> 2824386

Paired Epstein-Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: stimulatory capacity in allogeneic mixed lymphocyte cultures.

J Avila-Cariño1, S Torsteinsdottir, B Ehlin-Henriksson, G Lenoir, G Klein, E Klein, M G Masucci.   

Abstract

Epstein-Barr virus (EBV)-negative Burkitt lymphoma lines (BLE-) and their in vitro EBV-converted sublines (BLEc), obtained by infection with the P3HRI and B95-8 strains of EBV, were compared for their capacity to induce T-lymphocyte proliferation in allogeneic mixed lymphocyte cultures (MLC). Regardless of the virus strain used for conversion, the BLEc lines induced a considerably stronger primary MLC response than their EBV-negative parentals. Only the BLEc lines were able to maintain T-lymphocyte proliferation in repeated stimulations. The low proliferative response observed in cultures stimulated with BLE- cells was not due to the generation of suppressor cells or to the release of inhibitory factors. The increased stimulatory capacity of BLEc lines was unrelated to changes in expression of MHC class-I and class-II antigen, or of B-cell activation markers, and was not due to the reactivation of EBV-specific memory T cells, since lymphocytes from EBV-seropositive and seronegative donors responded similarly. The results indicate that the capacity of BL cells to elicit cellular immune responses may be influenced by their EBV-carrying status.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824386     DOI: 10.1002/ijc.2910400521

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.

Authors:  Martin S Staege; Steven P Lee; Teresa Frisan; Josef Mautner; Siegfried Scholz; Alexander Pajic; Alan B Rickinson; Maria G Masucci; Axel Polack; Georg W Bornkamm
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

2.  Search for the critical characteristics of phenotypically different B cell lines, Burkitt lymphoma cells and lymphoblastoid cell lines, which determine differences in their functional interaction with allogeneic lymphocytes.

Authors:  J Avila-Cariño; S Torsteinsdottir; B Ehlin-Henriksson; M G Masucci; E Klein
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Caspase-mediated degradation of human 5-lipoxygenase in B lymphocytic cells.

Authors:  Oliver Werz; Irina Tretiakova; Angela Michel; Annegret Ulke-Lemee; Michael Hörnig; Lutz Franke; Gisbert Schneider; Bengt Samuelsson; Olof Rådmark; Dieter Steinhilber
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-31       Impact factor: 11.205

4.  Protein-tyrosine kinase activity tightly associated with human type II Fc gamma receptors.

Authors:  G Sármay; I Pecht; J Gergely
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

5.  Monoclonal antibody against a lactose epitope of glycosphingolipids binds to melanoma tumour cells.

Authors:  K Ding; T Ekberg; J Zeuthen; S Teneberg; K A Karlsson; A Rosén
Journal:  Glycoconj J       Date:  1993-10       Impact factor: 2.916

6.  On the expression and regulation of 5-lipoxygenase in human lymphocytes.

Authors:  P J Jakobsson; D Steinhilber; B Odlander; O Rådmark; H E Claesson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

7.  Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.

Authors:  Ellen D Cahir-McFarland; Kara Carter; Andreas Rosenwald; Jena M Giltnane; Sarah E Henrickson; Louis M Staudt; Elliott Kieff
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.